Human papillomavirus (hpv)

Show results for

Unknown (5544)
Genomics (324)
Transcriptomics (271)
Proteomics (44)
Other (10)
Methylation profiling (5)
Clinical (4)
Metabolomics (4)
Genomic (2)

Organisms

Homo sapiens (320)
Schizophyllum commune H4-8 (31)
Mycobacterium tuberculosis SP7 (31)
Oryza sativa Japonica Group (31)
Candidatus Endoriftia persephonae (31)
Mycobacterium tuberculosis SP10 (31)
Mycobacterium tuberculosis SP13 (31)
Mycobacterium tuberculosis SP22 (31)
Enterobacter ludwigii (31)
Chlamydomonas reinhardtii (31)
Lama (31)
Pyricularia oryzae P131 (31)
Enterococcus mundtii CRL35 (31)
Oncorhynchus tshawytscha (31)
Pseudomonas canadensis (31)
Strongylocentrotus purpuratus (31)
Influenza A virus (A/California/04/2009(H1N1)) (31)
Homo (31)
Pseudomonas aeruginosa PAO1H2O (31)
Human alphaherpesvirus 1 strain 17 (31)
Mus musculus (23)
Human papillomavirus (7)
Cervus nippon (1)
Canis lupus familiaris (1)
Saccharomyces cerevisiae (1)
human papillomavirus 18 (1)
Human papillomavirus 16 (1)
synthetic construct (1)
Acyrthosiphon pisum (1)
cellular organisms (1)

Organisms

Homo sapiens (142)
Mus musculus (12)
Human papillomavirus (9)
human vaginal metagenome (3)
Human papillomavirus 16 (2)
Human papillomavirus sp. (1)
human skin metagenome (1)
Bacteria (1)
unidentified (1)

Repository

ENA (258)
biostudies-arrayexpress (180)
geo (137)
EGA (34)
pride (31)
MassIVE (9)
MetaboLights (4)
iProX (3)
dbGaP (2)
EVA (1)
GPMDB (1)
jPOST (1)

Tissue

Cell culture (13)
Keratinocyte (5)
Epithelial cell (5)
Tonsil (3)
Tongue (2)
Epithelial cell of cervix (2)
Blood serum (2)
T cell (2)
Oropharyngeal squamous cell carcinoma cell (1)
Palate (1)
Head and neck cancer cell (1)
Head and neck squamous cell carcinoma cell (1)
Peripheral blood mononuclear cell (1)
Malignant cell (1)
Bone marrow (1)
Permanent cell line cell (1)
Skin (1)

Disease

Cervix carcinoma (5)
Human papillomavirus infectious disease (4)
Head and neck squamous cell carcinoma (3)
Oropharynx cancer (2)
Squamous cell carcinoma (2)
Cervical cancer (2)
Human immunodeficiency virus infectious disease (2)
Integrated HPV16 only (1)
HPV positive (1)
Normal (1)
Uterine Cervical Neoplasms (1)
Colorectal Cancer (1)
Colonic Neoplasms (1)
Neoplasms (1)
Not Available (1)
Pharynx squamous cell carcinoma (1)
Tonsil squamous cell carcinoma (1)
Osteosarcoma (1)

Technology Type

Mass Spectrometry (31)
Shotgun proteomics (10)
Bottom-up proteomics (9)
Mass spectrometry (4)
Data-dependent acquisition (4)
Affinity purification coupled with mass spectrometry proteomics (4)
Data-independent acquisition (3)
SWATH MS (3)
MSE (2)
Gel-based experiment (2)
NextSeq 500 (ILLUMINA), Illumina HiSeq 2500 (ILLUMINA) (1)
Illumina HiSeq 2500, ILLUMINA (1)
454 GS FLX Titanium, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000 (1)
Proteogenomics (1)
DiaPASEF (1)
Immunopeptidomics (1)
Top-down proteomics (1)

Instrument Platform

NextSeq 500 (9)
Illumina HiSeq 2500 (4)
Illumina HiSeq 2000 (2)
Illumina HiSeq 4000 (2)
Illumina NovaSeq 6000 (2)
Orbitrap Fusion Lumos (2)
Orbitrap Eclipse (2)
DNBSEQ-G50 (1)
Illumina BeadArray Reader (part of Illumina BeadStation 500 (1)
ISCAN (1)
IScan Illumina (1)
The TLDA cards were analyzed on the Applied Biosystems 7900HT Real-Time PCR System. (1)
Illumina HiSeq X (1)
NextSeq 550 (1)
Instrument (1)
LTQ Orbitrap Velos (1)
LTQ Orbitrap XL (1)
Orbitrap Fusion (1)
LTQ Orbitrap (1)
Q Exactive (1)
Direct infusion MS - negative (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - HILIC (1)
Liquid Chromatography MS - positive - HILIC (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2014 (36)
2025 (34)
2013 (34)
2026 (26)
2016 (23)
2022 (21)
2015 (19)
2023 (18)
2021 (18)
2024 (17)
2012 (17)
2011 (17)
2018 (16)
2010 (12)
2008 (12)
2009 (11)
2020 (9)
2017 (9)
2019 (8)
2007 (6)
2005 (1)

CHEBI ID

CHEBI:17822 (2)
CHEBI:15940 (2)
CHEBI:16680 (2)
CHEBI:84058 (2)
CHEBI:17858 (2)
CHEBI:16742 (2)
CHEBI:17012 (2)
CHEBI:15676 (2)
CHEBI:15727 (2)
CHEBI:16704 (2)
CHEBI:17368 (2)
CHEBI:16335 (2)
CHEBI:16750 (2)
CHEBI:16708 (2)
CHEBI:16235 (2)
CHEBI:17562 (2)
CHEBI:16856 (2)
CHEBI:15354 (2)
CHEBI:15746 (2)
CHEBI:16919 (2)
CHEBI:17724 (2)
CHEBI:17154 (2)
CHEBI:32816 (2)
CHEBI:17929 (2)
CHEBI:30769 (2)
CHEBI:6650 (2)
CHEBI:18012 (2)
CHEBI:15741 (2)
CHEBI:17596 (2)
CHEBI:138900 (1)

Metabolite Name

Citicoline (2)
Guanosine monophosphate (2)
Cytidine monophosphate (2)
Gamma-L-Glutamyl-L-2-aminobutyrate (2)
IMP (2)
Argininosuccinic acid (2)
4-Hydroxyproline (2)
Guanosine (2)
Inosine (2)
Uridine (2)
Creatinine (2)
Glutathione (2)
HexCer(d32:1) (1)
Thymidine monophosphate (1)
CDP-DG(i-19:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) (1)
PG(i-14:0/6 keto-PGF1alpha) (1)
CDP-DG(18:1(12Z)-2OH(9,10)/a-17:0) (1)
CDP-DG(PGF1alpha/a-25:0) (1)
PG(18:0/PGE2) (1)
PE(20:5(5Z,8Z,11Z,14Z,17Z)/5-iso PGF2VI) (1)
PI(18:0/6 keto-PGF1alpha) (1)
PG(a-13:0/5-iso PGF2VI) (1)
Xi-p-Menth-3-en-1-ol (1)
N-[[(2S,3S,4R,5R)-3,4-Dihydroxy-5-[6-[(3-iodophenyl)methylamino]purin-9-yl]oxolan-2-yl]-hydroxymethyl]-N-methylformamide (1)
PE(5-iso PGF2VI/14:1(9Z)) (1)
CDP-DG(i-13:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) (1)
Lanabecestat (1)
(8R,9S,10R,13S,14S,17S)-17-Hydroxy-11,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one (1)
(2E,4E)-2,4-Nonadien-1-ol (1)
N'-[2-(3,5-Difluorophenyl)-2-hydroxyacetyl]-2-ethyl-4-hydroxy-3-methylbenzohydrazide (1)

First Public Date

2025 (36)
2026 (34)
2014 (31)
2021 (25)
2018 (23)
2022 (19)
2024 (18)
2023 (15)
2020 (15)
2017 (15)
2019 (9)
2015 (8)
2013 (7)
2016 (3)

Classification

viruses (12)

Modification

N6 (1)

Study status

Completed (2)
Not provided (1)
Recruiting (1)

Study type

Transcription profiling by array (93)
Methylation profiling by array (21)
RNA-seq of coding RNA (13)
Comparative genomic hybridization by array (10)
Genotyping by array (8)
MicroRNA profiling by array (5)
DNA-seq (4)
Unknown experiment type (3)
RNA-seq of coding RNA from single cells (3)
Interventional (3)
ChIP-chip by array (2)
Transcription profiling by RT-PCR (2)
MicroRNA profiling by high throughput sequencing (2)
ChIP-seq (2)
Methylation profiling by high throughput sequencing (2)
Transcription profiling by SAGE (1)
Human - Methylation microarray (1)
ChIP-chip by tiling array (1)
Human - One-color microarray (1)
Cell line - High-throughput sequencing (1)
RIP-seq (1)
Other (1)
RNA-seq of total RNA (1)
RNA-seq of non coding RNA (1)
Observational patient registry (1)

Release Date

2025 (633)
2022 (623)
2023 (570)
2021 (564)
2020 (454)
2024 (445)
2019 (388)
2018 (373)
2016 (280)
2017 (265)
2014 (242)
2015 (191)
2013 (156)
2011 (101)
2012 (100)
2026 (80)
2010 (66)
2009 (51)
2008 (41)
2007 (25)
2006 (15)
2005 (14)
2003 (14)
2004 (10)
2000 (9)
1999 (5)
2001 (4)
2002 (3)
1998 (2)

Lab affiliation

1 Department of Otorhinolaryngology - Head and Neck Surgery, University of Helsinki and HUS Helsinki University Hospital, P.O.Box 263, FI-00029 HUS, Helsinki, Finland 2 Department of Biosciences and Nutrition, Karolinska Institutet, SE-171 76, Stockholm, Sweden. 3 Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. (2)
Åbo Akademi University, Faculty of Science and Engineering, Finland (2)
Division of Viral Transformation Mechanisms, German Cancer Research Center (DKFZ), Heidelberg, Germany (1)
ProCan, Children’s Medical Research Institute, The University of Sydney, Westmead, NSW, Australia (1)
Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany (1)
Department of Biology University of Konstanz Germany (1)
Department of Biochemistry, Western University, Canada (1)
Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), Heidelberg, Germany. (1)
DKFZ F130 Division of Immunotherapy and Immunoprevention (1)
1Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA 2Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, Los Angeles, CA, USA 3Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, USA (1)
Associate Professor, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Blå Stråket 2, SE-41345, Göteborg, Sweden. (1)
Felix Hoppe-Seyler, Molecular Therapy of Virus-Associated Cancers, German Cancer Research Center (DKFZ), D-69120 Heidelberg, Germany (1)
WTSI (1)
Institute for Quantitative and Computational Biosciences (QCBio), University of California, Los Angeles, USA Department of Microbiology, Immunology, and Molecular Genetics (MIMG), University of California, Los Angeles, LA, USA Molecular Biology Institute, University of California, Los Angeles, USA (1)
Department of Otorhinolaryngology and Head & Neck Surgery, University Medical Center Ulm, Head and Neck Cancer Center of the Comprehensive Cancer Center Ulm, Ulm, Germany (1)
Laboratory MIVEGEC UMR5290 (CNRS IRD University Montpellier), French National Center for Scientific Research (CNRS), Montpellier, France (1)
Additional Professor, Deptt. of Medical Oncology (Lab), Dr BRAIRCH, AIIMS, New Delhi (1)
Univ. Lille, Inserm, CHU Lille, U1192 - Protéomique Réponse Inflammatoire Spectrométrie de Masse - PRISM, F-59000 Lille, France (1)
German Cancer Reseach Center (DKFZ) (1)
Cancer Research Institute, School of Basic Medical Science, Central South University (1)
Department of Zoology, University of Delhi, Delhi, India (1)
Director, Advanced Clinical Biosystems Research Institute (1)
Head of Mass Spectrometry Laboratory, Brazilian Biosciences National Laboratory (LNBio), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas, SP, Brazil. (1)
IMP - Research Institute of Molecular Pathology Campus-Vienna-Biocenter 1 1030 Vienna Austria (1)
Genecology Research Centre, University of the Sunshine Coast (1)
Department of Biology, University of Konstanz, Germany (1)
Additional Professor, Department of Medical Oncology (Lab.), Dr B.R.A.I.R.C.H., AIIMS, New Delhi (1)
European Institute of Oncology, Milan, Italy (1)
Max Planck Institute for Moleclar Biomedicine Bioanalyticyl Mass Spectrometry Unit Röntgenstr. 20 48149 Münster Germany (1)

Location

United States (2)
United Kingdom (1)
China (1)

Keyword

Bintrafusp Alfa M7824 (1)
NHS-IL12 M9241 (1)
PD-1(L1) (1)
Environmental barriers to cancer screening (1)
Person-level barriers to cancer screening (1)
Entinostat (1)
Immunotherapy (1)

Previous page
1 / 621
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 621
Next page

Sort by:

Relevance

Page size

MicroRNA sequencing and Novel HPV miRNA discovery in HPV cell lines and human tissue samples

Human papillomaviruses (HPV) preferentially infect keratinocytes of mucous membranes or skin and cause numerous benign and malignant lesions at different anatomical locations. A number of DNA viruses encode their own miRNAs as well. To date, no studies have been able to validate viral miRNAs in papi...

ORGANISM(S): Homo sapiens

2013-08-18 | E-GEOD-42380 | biostudies-arrayexpress

Methylome Analysis of FF HPV+ and HPV- HNSCC samples

The analysis of the 6 methylomes by MeDIP-Seq comprise 3 HPV+ HNSCC samples and 3 HPV- HNSCC samples Analysis of the 6 methylomes, comprising 3 HPV+ HNSCC samples and 3 HPV- HNSCC samples

ORGANISM(S): Homo sapiens

2012-11-01 | E-GEOD-38263 | biostudies-arrayexpress

Copy Number Alterations in HNSCC with or without Oncogene Expressing Human Papillomavirus

Oncogene expressing human papillomavirus type 16 (HPV16) is found in a subset of head and neck squamous cell carcinomas (HNSCC). HPV16 drives carcinogenesis by inactivating p53 and pRb with the viral oncoproteins E6 and E7, reflected by a low level of mutations in TP53 and allelic loss at 3p, 9p and...

ORGANISM(S): Homo sapiens

2009-05-26 | E-GEOD-11931 | biostudies-arrayexpress

Transcription profiling of human HPV-immortalized keratinocytes

To identify early processes in carcinogenesis, we used an in vitro model, based on the initiating event in cervical cancer, human papillomavirus (HPV) transformation of keratinocytes. We compared gene expression in primary keratinocytes (K) and HPV16-transformed keratinocytes from early (E) and late...

ORGANISM(S): Homo sapiens

2009-05-02 | E-GEOD-15156 | biostudies-arrayexpress

Transcription profiling of human head and neck squamous cell carcinomas that are positive or negative for Human Papilloma Virus

Introduction: Human Papilloma Virus (HPV) is associated with a subset of head and neck squamous cell carcinoma (HNSCC), between 15% and 35% of HNSCC harboring HPV, almost exclusively of subtype 16. Demographic and exposure differences between HPV-positive (+) and negative (-) HNSCCs suggest that HPV...

ORGANISM(S): Homo sapiens

2007-09-20 | E-GEOD-3292 | biostudies-arrayexpress

Subtypes of HPV-positive head and neck cancers are associated with HPV characteristics, copy number variations, PIK3CA mutation, and pathway signatures. [RNA-Seq]

Purpose: There is substantial heterogeneity within the human papillomavirus (HPV) positive head and neck cancer (HNC) tumors that predispose them to different outcomes, however this subgroup is poorly characterized due to various historical reasons. Experimental Design: we perform unsupervised gene...

ORGANISM(S): Homo sapiens

2016-05-13 | E-GEOD-74927 | biostudies-arrayexpress

Immortalization capacity of HPV types is inversely related to chromosomal instability in immortal descendants.

Human papillomavirus (HPV) induced immortalization of human foreskin keratinocytes (HFK) is a two-step process, including 1) the bypass of replicative senescence and acquisition of an extended lifespan, and 2) the outgrowth of immortal cells. Our previous study showed that the immortalization capaci...

ORGANISM(S): Homo sapiens

2016-08-01 | E-GEOD-72063 | biostudies-arrayexpress

Epigenome analysis in HPV(-) and HPV(+) squamous cell carcinoma cell lines

Human papillomavirus (HPV)-associated head and neck cancers (HNSCCs) have a distinct risk profile and appreciate a prognostic advantage compared to HPV-negative HNSCC. Promoter hypermethylation has been widely recognized as an important mechanism in the progression of HNSCC, but the extent to which ...

ORGANISM(S): Homo sapiens

2010-12-01 | E-GEOD-24087 | biostudies-arrayexpress

RNA-seq of human skin lesions diagnosed as actinic keratosis, intraepidermal carcinoma or squamous cell carcinoma

We report whole tissue RNA-seq data captured from 25 AK, IEC or SCC lesions obtained from the skin of 17 individuals. We used RNA-seq to detect and measure HPV E7 transcription.

ORGANISM(S): Homo sapiens

2018-07-09 | E-MTAB-6430 | biostudies-arrayexpress

Transcription profiling of human HPV-positive and -negative head/neck and cervical cancers

Human papillomaviruses (HPVs) are associated with nearly all cervical cancers (CCs), 20-30% of head and neck cancers (HNCs), and other cancers. Because HNCs also arise in HPV-negative patients, this type of cancer provides unique opportunities to define similarities and differences of HPV-positive v...

ORGANISM(S): Homo sapiens

2008-06-15 | E-GEOD-6791 | biostudies-arrayexpress

Previous page
1 / 621
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 621
Next page

Sort by:

Relevance

Page size

6209 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Modification

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets